 According to the original purchase agreement signed on April 11, 2019, the aggregate purchase price for the shares of Boqi Pharmacy or Boqi Pharmacys parent consists of a cash consideration of RMB 40,000,000 currently approximately US5,714,285 the Target Cash Considerationand 1,500,000 shares of common stock of the Company. The Target Cash Consideration is subject to post-closing adjustment according to the appraised value of Boqi Pharmacy. 